CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)	Common Stock [Member]	Common Stock Be Issued [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2020	$ 70	$ 336,000	$ 42,773,378		$ (45,893,368)	$ (2,783,920)
Beginning balance, shares at Dec. 31, 2020	695,576
Stock issued for conversion of non-redeemable convertible notes	$ 45		1,964,576			1,964,621
Stock issued for conversion of non-redeemable convertible notes, shares	452,324
Stock issued for conversion of convertible notes	$ 6		218,121			218,127
Stock issued for conversion of convertible notes, shares	63,672
Stock issued for consulting	$ 3		269,997			270,000
Stock issued for consulting, shares	30,000
Stock issued for officer and director compensation			20,350			20,350
Stock issued for officer and director compensation, shares	4,000
Net loss					(2,891,421)	(2,891,421)
Ending balance, value at Mar. 31, 2021	$ 124	336,000	45,246,422		(48,784,789)	(3,202,243)
Ending balance, shares at Mar. 31, 2021	1,245,572
Beginning balance, value at Dec. 31, 2020	$ 70	336,000	42,773,378		(45,893,368)	(2,783,920)
Beginning balance, shares at Dec. 31, 2020	695,576
Ending balance, value at Dec. 31, 2021	$ 600	336,000	58,151,817	4,870	(62,229,405)	(3,736,118)
Ending balance, shares at Dec. 31, 2021	6,000,000
Stock issued for conversion of non-redeemable convertible notes	$ 101		684,899			685,000
Stock issued for conversion of non-redeemable convertible notes, shares	1,010,000
Foreign exchange loss				(1,183)		(1,183)
Net loss					(1,353,597)	(1,353,597)
Ending balance, value at Mar. 31, 2022	$ 701	$ 336,000	$ 58,836,716	$ 3,687	$ (63,583,002)	$ (4,405,898)
Ending balance, shares at Mar. 31, 2022	7,010,000